Michael Tansey tapped as chief of Wicks Medical Unit
At Wicks Medical,Tansey will lead a firm that operates in the medical information services market and "concentrates on growth by acquisition of companies in the medical education and publishing sectors," according to a company statement.
At Thomson, Tansey was a group chief executive of Thomson Scientific and Healthcare, and oversaw the business units ISI, Derwent and Current Drugs. During this period, he was responsible for the successful acquisition and integration of five businesses and implementation
of a group-wide customer focused reorganization. Wicks is a New York-based investment firm specializing in communications, information and media businesses.